🔎 Trials Near Me

Utama › Kanser Kolon › Illinois › Chicago

Kajian klinikal Kanser Kolon di Chicago, IL

14 kajian untuk Kanser Kolon sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Family Communications After Genetic Testing

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Advocate Illinois Masonic Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487

PRE-ISPY Phase I/II Oncology Platform Program

Mengambil pesertaFasa 1/2
  • The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05868226

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Mengambil pesertaFasa 3
  • Illinois Cancer Specialists, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Mengambil pesertaFasa 3
  • University of Illinois Cancer Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07284849

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Mengambil peserta
  • John H Stroger Jr Hospital of Cook County, Chicago
Umur 45 hingga 70 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Mengambil pesertaFasa 2/3
  • Mount Sinai Hospital Medical Center, Chicago
  • Northwestern University, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • dan 5 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05174169

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Mengambil pesertaFasa 1/2
  • Northwestern University, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07594626

Shield Post-Approval Study Protocol

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • GI Solutions of Illinois, Chicago
  • GI Solutions of Illinois, Chicago
Umur 45 hingga 81 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06880055

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Mengambil pesertaFasa 1
  • Xencor Investigative Site, Chicago
  • Xencor Investigative Site, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT05433142

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

Mengambil pesertaFasa 2
  • City of Hope at Illinois Chicago Downtown, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jul 2026 · NCT07595874

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • University of Chicago, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Umur 18 hingga 49 · Semua jantina · Dikemas kini 24 Apr 2026 · NCT05732623

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Mengambil pesertaFasa 3
  • GSK Investigational Site, Chicago
  • GSK Investigational Site, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jan 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Chicago
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Kolon di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.